Cytochrome P450 3A-Dependent Metabolism of a Potent and Selective γ-Aminobutyric Acid Aα2/3 Receptor Agonist in Vitro: Involvement of Cytochrome P450 3A5 Displaying Biphasic Kinetics
Drug Metabolism and Disposition, ISSN: 0090-9556, Vol: 35, Issue: 8, Page: 1301-1307
2007
- 8Citations
- 11Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations8
- Citation Indexes8
- CrossRef8
- Captures11
- Readers11
- 11
- Mentions1
- References1
- Wikipedia1
Article Description
In vitro metabolism studies were conducted to determine the human cytochrome P450 enzyme(s) involved in the biotransformation of 7-(1,1-dimethylethyl)-6-(2-ethyl-2 H -1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3 b ]pyridazine (TPA023), a selective agonist of human γ-aminobutyric acid A receptor α2 and α3 subunits. Incubation of TPA023 with NADPH-fortified human liver microsomes resulted in the formation of t -butyl hydroxy TPA023, N -desethyl TPA023, and three minor metabolites. Both t -butyl hydroxylation and N -deethylation reactions were greatly inhibited (>85%) in the presence of CYP3A-selective inhibitory antibodies and chemical inhibitors, indicating that members of the CYP3A subfamily play an important role in TPA023 metabolism. Eadie-Hofstee plots of t -butyl hydroxylation and N -deethylation in pooled CYP3A5-rich human liver microsomes revealed a low K m (3.4 and 4.5 μM, respectively) and a high K m (12.7 and 40.0 μM, respectively) component. For both metabolites, the high K m component was not observed with a pool of microsomal preparations containing minimal levels of CYP3A5. Preincubation of liver microsomes with mifepristone (selectivity for CYP3A4 > CYP3A5) greatly inhibited both t -butyl hydroxylation and N -deethylation (>75%); however, the residual activities were significantly higher in the pooled CYP3A5-rich liver microsomes ( p < 0.0005). In addition, elevated levels of residual t -butyl hydroxylase and N -deethylase activities were observed in the presence of both CYP3A5-rich and CYP3A5-deficient preparations when the substrate concentration increased from 4 to 40 μM. In agreement, metabolite formation catalyzed by recombinant CYP3A5 was described by a biphasic model. It is concluded that CYP3A4 plays a major role in TPA023 metabolism, and CYP3A5 may also contribute at higher concentrations of the compound.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S009095562401376X; http://dx.doi.org/10.1124/dmd.107.014753; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=34547169021&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/17460031; https://linkinghub.elsevier.com/retrieve/pii/S009095562401376X; https://dx.doi.org/10.1124/dmd.107.014753; https://dmd.aspetjournals.org/content/35/8/1301
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know